Literature DB >> 755032

The diagnostic potential of contrast enhancement pharmacokinetics.

P B Dean, L Kivisaari, M Kormano.   

Abstract

Diastizoate concentrations in the blood and twelve tissues and organs of 20 rats were measured at 40 seconds, and 2, 5, 15 and 60 minutes after bolus intravenous administration of 125 I-labeled diatrizoate and 131 I-labeled albumin. Contrast enhancement (HU) and distribution volumes(%) were calculated from this data, and the results are presented graphically. The tissues can be separated into two groups according to the rapidity of extravascular contrast medium uptake. The liver appeared to concentrate the contrast medium. Curves of local contrast enhancement with time could be constructed by a CT scanner from the data of several consecutive scans and are of potential importance in the differential diagnosis of lesions detected on CT. Repeat postcontrast CT scans could be used to detect and characterize lesions which raise a diagnostic problem. The potential diagnostic advantages of calculating percent distribution volumes from CT scans are demonstrated and discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 755032     DOI: 10.1097/00004424-197811000-00010

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  3 in total

1.  Development of a theory for generating regional cardiac perfusion images during coronary angiography in the coronary angiography lab.

Authors:  Takuya Sakaguchi; Takashi Ichihara; Jeffrey C Trost; Omair Yousuf; Joao A C Lima; Jingwu Yao; Richard T George
Journal:  Int J Cardiovasc Imaging       Date:  2013-10-12       Impact factor: 2.357

Review 2.  An overview of the clinical pharmacokinetics of x-ray contrast media.

Authors:  M Bourin; P Jolliet; F Ballereau
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

3.  Evaluation of hepatic density change by dynamic CT in healthy humans and in patients with chronic liver diseases.

Authors:  S Sugano; T Okajima; S Kubo; Y Yamazaki; Y Sumino; T Abei
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.